Flexitive helps brands and agencies automate omnichannel design production and distribution. The company provides advanced responsive design and automation technology for marketing and design teams to work together.

Flexitive

23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to improve patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing of intellectual property associated with identified drug targets related to drug candidates under clinical development. It has a collaboration agreement with GlaxoSmithKline Intellectual Property (No.3) Limited to leverage genetic insights to validate, develop, and commercialize drugs. The company was founded in 2006 and is headquartered in South San Francisco, California.

Linda Avey

Paul Cusenza

Anne Wojcicki

23andMe Holding Co.

6 River Systems offers an industry-leading warehouse automation system that combines advanced fulfillment algorithms with autonomous mobile robots (AMRs) to boost warehouse productivity, exceed customer expectations, and reduce risk.

Jerome Dubois

Rylan Hamilton

Christopher Cacioppo

6 River Systems

Alert Innovation is a technology and robotics company that specializes in designing and building innovative automated solutions for retail and e-commerce fulfillment.

Metric
Company Name	Flexitive	23	6	Alert Innovation
Symbol		ME
MSH ID	COM:FLEXITIVE	COM:23ANDME	COM:6RIVER	COM:ALERTINNOVATION
Market	PRIVATE	STOCKS	PRIVATE	PRIVATE
Sector	Technology	Healthcare	Commercial & Professional Services	Technology
Industry	Marketing Technology	Medical - Diagnostics & Research	Warehouse Automation	Technology
Country	US	US
Stage
Employee Count		560	251	101
Website	flexitive.com	23andme.com	6river.com	alertinnovation.com
LinkedIn		23andme
Founders

Metric
Market Cap		225.52M
Enterprise Value
Monthly Web Traffic	13.95K	6.55M
Web Traffic Growth	4.28	-0.06
Valuation
Raised Capital

Metric
Revenue		219.64M
Revenue (LTM)
Revenue (NTM)
Gross Profit		99.38M
EBITDA		-291.88M
Operating Income		-321.36M
Net Income		-666.70M
EPS		-1.40
Diluted EPS		-1.40
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.45
Operating Profit Margin		-2.17
EBITDA Margin		-1.33
Net Profit Margin		-2.10
Return on Equity		-0.87
Return on Assets		-0.86
Return on Capital Employed		-1.16

FLEX

COM:FLEXITIVE

Flexitive

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		-0.93
P/B Ratio		0.50
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		13.37
EV Multiple		-3.85

Metric
Days Sales Outstanding		2.03
Days Payables Outstanding		21.21
Days Inventory Outstanding		48.94
Operating Cycle		97.37
Cash Conversion Cycle		62.09
Asset Turnover		0.56

Metric
Operating Cash Flow		-155.53M
Free Cash Flow		-165.19M
Cash Flow to Debt		-1.75
Operating Cash Flow/Sales		-0.65
Free Cash Flow Yield		-0.50

Metric
Cash & Equivalents		217.89M
Accounts Receivable		-1.43M
Inventory		12.46M
Goodwill
Debt to Capitalization		0.34
Debt to Assets		0.10
Current Ratio		2.93
Quick Ratio		1.87

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.49
R&D to Revenue		0.87
SG&A to Revenue		0.53